WASHINGTON — The first clinical trials that examine the use of stem cells to treat two forms of blindness are ready to begin now that patients have been enrolled, a US company announced on Thursday.
Human embryonic stem cells will be tested as a treatment for blindness, a US company announced Monday in the second such clinical trial to examine how the controversial process works in people.
